Document is current
Any future updates will be listed below
-
Authors
Morello, William https://orcid.org/0000-0002-4833-4128
Budelli, Silvia
Bernstein, Daniel Ari
Montemurro, Tiziana
Montelatici, Elisa
Lavazza, Cristiana
Ghio, Luciana
Edefonti, Alberto
Peruzzi, Licia
Molino, Daniela
Benetti, Elisa
Gianoglio, Bruno
Mehmeti, Florian
Catenacci, Laura
Rotella, Jessica
Tamburello, Chiara
Moretta, Antonia
Lazzari, Lorenza
Giordano, Rosaria
Prati, Daniele
Montini, Giovanni https://orcid.org/0000-0002-7350-4475
-
Funding
Funding for this research was provided by:
Fondazione “La Nuova Speranza” Onlus
- License Information
-
More Information
Article History
Received: 23 April 2022
Accepted: 3 August 2022
First Online: 19 August 2022
Declarations
:
: The study was approved by the local ethics committee (Comitato Etico Milano Area 2) and by the national competent authorities for clinical trial authorization (Istituto Superiore di Sanità and Agenzia Italiana del Farmaco [AIFA]). The trial was registered befor the enrollment of the first patient (EudraCT number 2011-001387-21). An informed consent was obtained from the legal guardians of all patients.
: Not applicable.
: The authors have no conflicts of interest relevant to this article to disclose.
